Identifying Pathological Tau Aggregates as a Biomarker in CSF of Alzheimer’s Disease Patients
Time: 8:30 am
day: Blood-Based Biomarker Focus Day
Details:
- Differentiating isolation approaches applied to identify seeding competent tau aggregates from AD brain homogenates
- Generating high-affinity antibodies towards specific conformations and phospho sites of pathological tau
- Harnessing them to identify tau aggregates in CSF of Alzheimer’s disease
